Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $SGEN Seagen Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).

Baker Brothers Life Sciences Capital (GP), LLC in Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 15,131,223 shares
Current Value: $919,827,046
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in Seagen Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADLR, IBPI, AUXL, BCRX, GHDX, HRTX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 04 2012	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Option Exercise	X	6.25	355,143	2,219,644	0
Jan 04 2012	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	X	6.25	355,143	2,219,644	15,131,223	14.8 M to 15.1 M (+2.40 %)
Sep 08 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	17.27	19,729	340,700	14,776,080	14.8 M to 14.8 M (+0.13 %)
Sep 08 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	17.06	78,326	1,336,547	14,756,351	14.7 M to 14.8 M (+0.53 %)
Sep 08 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	17.00	31,132	529,393	14,678,025	14.6 M to 14.7 M (+0.21 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	15.35	8,767	134,575	14,646,893	14.6 M to 14.6 M (+0.06 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	15.53	469,862	7,296,534	14,638,126	14.2 M to 14.6 M (+3.32 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	15.45	506,221	7,822,734	14,168,264	13.7 M to 14.2 M (+3.71 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	14.98	3,371	50,485	13,662,043	13.7 M to 13.7 M (+0.02 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	14.98	6,205	92,947	13,658,672	13.7 M to 13.7 M (+0.05 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	14.79	166,638	2,464,576	13,652,467	13.5 M to 13.7 M (+1.24 %)
Aug 25 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	P	14.60	4,371	63,812	13,485,829	13.5 M to 13.5 M (+0.03 %)
Jul 05 2011	SGEN	SEATTLE GENETICS I ...	Baker Brothers Life Sciences C ...	Director	Buy	J	0.00	10,766	0	13,481,458	13.5 M to 13.5 M (+0.08 %)

Page: 1